Navigation Links
Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
Date:5/12/2008

NEW YORK, May 13 /PRNewswire/ -- Johnson & Johnson today announced that Professor Marc Feldmann, FMedSci, FAA, FRS and Emeritus Professor Sir Ravinder N. Maini, FRCP, FMedSci, FRS of the Kennedy Institute of Rheumatology, Imperial College London have been named the recipients of the 2008 Dr. Paul Janssen Award for Biomedical Research by an independent selection committee of world-renowned scientists.

The award salutes the most passionate and creative scientists in basic or clinical research, whose scientific achievements have made, or have strong potential to make, a measurable impact on human health. Feldmann and Maini were selected for their role in the discovery of tumor necrosis factor-alpha, or TNF-alpha, as an effective therapeutic target for rheumatoid arthritis and other chronic inflammatory conditions afflicting millions worldwide. The award, which includes a $100,000 prize, will be presented to the winners at events in New York and Beerse, Belgium in September.

According to Solomon Snyder, Ph.D., Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry, Johns Hopkins School of Medicine and Chairman, Janssen Award Selection Committee, "The work of Feldmann and Maini exemplifies the bench-to-bedside approach that Paul Janssen's contributions epitomized. It is extremely rare for researchers to identify a molecular messenger in test tube studies, demonstrate its physiologic relevance in animals and themselves carry these efforts forward to a successful clinical demonstration. Feldmann and Maini did all of this, leading to therapeutic agents of inestimable, lifesaving importance."

Established by Johnson & Johnson, the Dr. Paul Janssen Award for Biomedical Research honors the founder of Janssen Pharmaceutica. Known to his colleagues as "Dr. Paul," Janssen was one of the 20th century's most gifted and passionate researchers, a physician-scientist who helped save millions of lives through his contribution to the disc
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development,L.L.C.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
2. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
3. Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity
4. President and CEO of Velcura Therapeutics Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year
5. Black Box Network Services, ABTECH, Verizon Business and Wyle Named Top Siemens Reseller Partners
6. BioNanomatrix Named Best Management Team at the 2008 Ben Franklin Emerging Business Awards
7. Ash Stevens Inc. Named One of Michigan 50 Companies to Watch
8. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
9. James W. Backstrom, M.D., Named Chief Medical Officer of Foundation Radiology Group
10. Sumitomo Corporation of America Named Exclusive Distribution and Sales Agent for Chiral Quest
11. Leading Geneticist Francis Collins Named First Recipient of the Inamori Ethics Prize at Case Western Reserve University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...FirstCall/ -- AstraZeneca (NYSE:,AZN) today announ...A) has,approved once-daily SEROQUEL XR(R) (quetiap...te treatment of the depressive episodes associated...es associated with bipolar I,disorder, and the mai...tive,therapy to lithium or divalproex. SEROQUEL XR...
(Date:10/10/2008)...Takeda Pharmaceutical Company,Limited ("Takeda") t...elopment Center, Inc., a wholly owned United State...e U.S. Food and Drug Administration (FDA) will,not...New Drug Application,(NDA) by the Prescription Dru... "In our most recent discussion with the FDA, it i...
(Date:10/9/2008)...up six spots from last year, ST. LOUIS, Oct. 9 /P...N) is earning recognition as a leader in biotechno... also for being a great place to work., Monsanto,... place in,the 2008 Top Biotech and Pharma Employer... The company moved up six spots from number eight ...
(Date:10/9/2008)... - Dr. Brad Thompson, President,and CEO of Oncolyt...esent a,corporate overview of the Company at the 1...on, U.K. on Monday, October 13 at 2 p.m. The confe...nference Centre from October,12-14, 2008., About ...based biotechnology company focused on the,develop...
Breaking Biology Technology:FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 2FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 3FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 4FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 5FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 6FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 7FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 8FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania 9FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2Monsanto Recognized as Top Biotechnology Employer by Science Magazine 2Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe 2
... stories to tell, but perhaps nothing is more illu...ory of a little girl drawing in the back of a clas...ul Getty Trust in Los Angeles and an internationa..., told the story during a keynote address at the a...Association Conference. , ,Noting that young chil...
...ago Bar Association entitled "Communication Rights...t Century." At that time, many who attended thou...faith in it. My argument was that the horse-and-bu...d liquor were maxed out. Municipalities would have...ms that could pay for services and pensions. , ,Th...
...n Internet data provider, has appointed its legal ...ions officer. , ,Meier brings experience in the le...and he will be responsible for helping the Milwauk...and business development programs. , ,"I believe i...go when it was just two people and an idea," Donat...
...and his company through a series of mergers and pe...der of JT Packard & Associates, Inc. , Cason pres...er. The company has grown by 500 percent over the ...ptible power supply (UPS) service company in the c...,With its recent purchase by Anaheim, Calif.-based...
Other Biology Technology:Sir Ken Robinson: Companies, kids "get" innovation, but K-12 doesn't nurture it 2Sir Ken Robinson: Companies, kids "get" innovation, but K-12 doesn't nurture it 3Creativity, innovation extend to municipalities 2Creativity, innovation extend to municipalities 3Creativity, innovation extend to municipalities 4Power services firm JT Packard isn't through growing 2Power services firm JT Packard isn't through growing 3
(Date:10/10/2008)...ry researchers have found that statins may be able...g from pregnancy complications caused by antiphosp...ce. In this autoimmune syndrome, the body produces...mponents of cell membranes. This news comes from a...nal of Clinical Investigation that is currently o...
(Date:10/10/2008)...f Kyoto University and the Gladstone Institute of ...ep forward in improving the possibilities for the ...(iPS) cell technology. , Previously, Dr. Yamanak...o become embryonic stem celllike using a cancer-ca...o reprogram the cells, and a virus to transfer the...
(Date:10/10/2008)..., Gasterosteus aculeatus , is one of the most tho...n a particularly useful model for understanding va...morphology caused by different ecological situatio...cular and genetic to developmental and morphologic...it has proven far more complex than even imagined....
(Date:10/10/2008)... in German . , DNA, the molecule that acts as...f life, is highly resistant against alteration by ... for its photostability presents some puzzling pro... four chemical bases that make up the DNA molecule... showing that DNA strands differ in their light se...
Breaking Biology News(10 mins):Statins may prevent miscarriages 2Statins may prevent miscarriages 3Yamanaka eliminates viral vector in stem cell reprogramming 2Fitness in a changing world 2Fitness in a changing world 3Can genetic information be controlled by light? 2Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases 1932 1Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases 1932 2Engineers harness cell phone technology for use in medical imaging 4950 1Engineers harness cell phone technology for use in medical imaging 4950 2Engineers harness cell phone technology for use in medical imaging 4950 3Engineers harness cell phone technology for use in medical imaging 4950 4Viscosity Enhancers Curb Bleeding Complications 17971 1Viscosity Enhancers Curb Bleeding Complications 17971 2Genes Linked to Osteoporosis Identified 17967 1Genes Linked to Osteoporosis Identified 17967 2Genes Linked to Osteoporosis Identified 17967 3
...f Medicine researchers have discovered how new neu...nt to regions of the brain where they can replace ...tem cell therapies can be specifically targeted to...ses or by stroke. , Associate Professor Qun-Yong Z...artment of Pharmacology have identified a protein ...
... the world are breathing a sigh of relief, as they...ir natural disease-fighting substances. Scientists... didemnii, which lives symbiotically inside the se...es, compounds that may one day be used in cancer t...s could not successfully cultivate Prochloron in t...
...sma protein found in blood, can be fused with larg...stimulating factor (G-CSF) to create a new oral co...rough the gastrointestinal (GI) tract and then abl... the body, according to research from the Universi...is technology may allow for oral administration of...
...factors prove that BioMed Central,s Open Access jo... Journals published by BioMed Central have again r...valent subscription titles, it was announced today...lty. The high impact factors for these journals af...re fast becoming the place for authors to submit i...
Other Biology News:Researchers discover stem cell 'guide' that may be key for targeting neural stem cell treatments 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 3'Bionic' arm gives amputee sense of touch 2
...itivity Laboratory Osmometer for both 0.2 and 2.0 ...ludes built-in printer, keypad, and software for s...reading capability with optional scanner. RS-232 p...Two-step Calibration. ...
MAb to Hu-IFN-Gamma RC2 (CD118), NON-Neutralizing, Clone MMHGR-2 Binds to but does not neutralize human interferon gamma receptor
Recombinant Rat CINC-2 alpha, CF
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice
Biology Products: